Cambridge Investment Research Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,789
| Closed | -$221K | – | 3235 |
|
|
2023
Q1 | $221K | Buy |
3,789
+288
| +8% | +$16.8K | ﹤0.01% | 2747 |
|
|
2022
Q4 | $217K | Sell |
3,501
-1,146
| -25% | -$71K | ﹤0.01% | 2687 |
|
|
2022
Q3 | $263K | Buy |
4,647
+447
| +11% | +$25.3K | ﹤0.01% | 2472 |
|
|
2022
Q2 | $268K | Sell |
4,200
-33
| -0.8% | -$2.11K | ﹤0.01% | 2483 |
|
|
2022
Q1 | $274K | Sell |
4,233
-702
| -14% | -$45.4K | ﹤0.01% | 2617 |
|
|
2021
Q4 | $328K | Buy |
4,935
+123
| +3% | +$8.18K | ﹤0.01% | 2444 |
|
|
2021
Q3 | $294K | Buy |
4,812
+666
| +16% | +$40.7K | ﹤0.01% | 2483 |
|
|
2021
Q2 | $257K | Buy |
+4,146
| New | +$257K | ﹤0.01% | 2591 |
|
|
2021
Q1 | – | Sell |
-5,274
| Closed | -$315K | – | 2929 |
|
|
2020
Q4 | $315K | Sell |
5,274
-66
| -1% | -$3.94K | ﹤0.01% | 2093 |
|
|
2020
Q3 | $291K | Sell |
5,340
-315
| -6% | -$17.2K | ﹤0.01% | 1955 |
|
|
2020
Q2 | $290K | Buy |
5,655
+594
| +12% | +$30.5K | ﹤0.01% | 1909 |
|
|
2020
Q1 | $227K | Buy |
5,061
+384
| +8% | +$17.2K | ﹤0.01% | 1849 |
|
|
2019
Q4 | $250K | Buy |
4,677
+129
| +3% | +$6.9K | ﹤0.01% | 2036 |
|
|
2019
Q3 | $212K | Buy |
4,548
+135
| +3% | +$6.29K | ﹤0.01% | 2071 |
|
|
2019
Q2 | $222K | Sell |
4,413
-249
| -5% | -$12.5K | ﹤0.01% | 1938 |
|
|
2019
Q1 | $239K | Sell |
4,662
-1,251
| -21% | -$64.1K | ﹤0.01% | 1953 |
|
|
2018
Q4 | $277K | Sell |
5,913
-156
| -3% | -$7.31K | ﹤0.01% | 1710 |
|
|
2018
Q3 | $340K | Buy |
6,069
+690
| +13% | +$38.7K | ﹤0.01% | 1717 |
|
|
2018
Q2 | $271K | Buy |
5,379
+75
| +1% | +$3.78K | ﹤0.01% | 1810 |
|
|
2018
Q1 | $261K | Sell |
5,304
-462
| -8% | -$22.7K | ﹤0.01% | 1772 |
|
|
2017
Q4 | $297K | Buy |
5,766
+1,884
| +49% | +$97K | ﹤0.01% | 1667 |
|
|
2017
Q3 | $202K | Sell |
3,882
-240
| -6% | -$12.5K | ﹤0.01% | 1824 |
|
|
2017
Q2 | $213K | Sell |
4,122
-582
| -12% | -$30.1K | ﹤0.01% | 1716 |
|
|
2017
Q1 | $237K | Sell |
4,704
-1,875
| -28% | -$94.5K | ﹤0.01% | 1526 |
|
|
2016
Q4 | $310K | Buy |
6,579
+180
| +3% | +$8.48K | 0.01% | 1253 |
|
|
2016
Q3 | $319K | Sell |
6,399
-117
| -2% | -$5.83K | 0.01% | 1265 |
|
|
2016
Q2 | $314K | Buy |
6,516
+987
| +18% | +$47.6K | 0.01% | 1155 |
|
|
2016
Q1 | $252K | Sell |
5,529
-969
| -15% | -$44.2K | 0.01% | 1266 |
|
|
2015
Q4 | $350K | Sell |
6,498
-1,143
| -15% | -$61.6K | 0.01% | 1060 |
|
|
2015
Q3 | $377K | Sell |
7,641
-2,700
| -26% | -$133K | 0.01% | 909 |
|
|
2015
Q2 | $603K | Buy |
10,341
+2,619
| +34% | +$153K | 0.02% | 718 |
|
|
2015
Q1 | $444K | Buy |
7,722
+1,101
| +17% | +$63.3K | 0.01% | 855 |
|
|
2014
Q4 | $334K | Sell |
6,621
-24
| -0.4% | -$1.21K | 0.01% | 966 |
|
|
2014
Q3 | $311K | Buy |
6,645
+1,536
| +30% | +$71.9K | 0.01% | 1074 |
|
|
2014
Q2 | $230K | Buy |
+5,109
| New | +$230K | 0.01% | 1131 |
|